Upcoming Investor Events for Compass Therapeutics
Compass Therapeutics, Inc. (NASDAQ: CMPX), a biopharmaceutical company dedicated to developing innovative antibody-based therapies targeting cancer, has announced its participation in several significant investor events in December. This provides a wonderful opportunity for investors to engage with the company and gain insights into its promising pipeline of clinical initiatives.
Details of the December Events
Here's what you can expect in December:
Piper Sandler 37th Annual Healthcare Conference
Location: New York, NY
Date: Tuesday, December 2, 2025
Time: 8:00 AM ET
8th Annual Evercore Healthcare Conference
Location: Coral Gables, FL
Date: Thursday, December 4, 2025
Time: 10:00 AM ET
Virtual Presentations and Access
For those unable to attend in person, Compass Therapeutics will archive presentations for 90 days. Interested investors can find more details by visiting the company’s Events page.
Meet with Management
Management at Compass Therapeutics will be available throughout these events for one-on-one meetings. Investors interested in discussing the company’s strategic direction and innovative pipeline should reach out to their representatives.
About Compass Therapeutics
Founded in 2014, Compass Therapeutics, Inc. focuses on creating proprietary antibody therapies for the treatment of various conditions, particularly in oncology. The company emphasizes the importance of understanding how angiogenesis, the immune system, and tumor growth relate to effective cancer treatment. Their robust pipeline includes several unique candidates aiming to engage multiple biological pathways critical for boosting anti-tumor immune responses.
Compass Therapeutics is committed to advancing its promising product candidates through both standalone and combination therapies, leveraging robust preclinical and clinical data. More information about their innovative work can be found on their website.
Contact Information for Investors
For any inquiries, interested parties are encouraged to contact:
Investor Relations: ir@compasstherapeutics.com
Media Inquiries
Media Contact:
Anna Gifford, Chief of Staff
media@compasstherapeutics.com | 617-500-8099
Frequently Asked Questions
What is the significance of Compass Therapeutics participating in these events?
Participation allows Compass to present their latest developments and engage with the investment community.
How can I access presentations if I cannot attend the events?
Compass Therapeutics will archive their presentations for 90 days, which can be accessed on their Events page.
What type of therapies does Compass Therapeutics develop?
The company develops antibody-based therapeutics primarily targeting oncology.
Who can I contact for more information about investor relations?
Investors can reach out via email to their investor relations at ir@compasstherapeutics.com.
Where can I find more information about their products and research?
Further information is available on the Compass Therapeutics official website.